Index RUT
P/E -
EPS (ttm) -1.76
Insider Own 12.25%
Shs Outstand 82.56M
Perf Week 16.24%
Market Cap 2.50B
Forward P/E -
EPS next Y -4.84
Insider Trans -2.16%
Shs Float 72.66M
Perf Month 11.60%
Income -143.59M
PEG -
EPS next Q -1.27
Inst Own 81.95%
Short Float 16.47%
Perf Quarter 25.21%
Sales 349.64M
P/S 7.15
EPS this Y -174.65%
Inst Trans 5.98%
Short Ratio 11.83
Perf Half Y 21.48%
Book/sh 9.58
P/B 3.15
EPS next Y -2.45%
ROA -11.67%
Short Interest 11.97M
Perf Year 14.39%
Cash/sh 11.18
P/C 2.70
EPS next 5Y -3.70%
ROE -18.29%
52W Range 20.84 - 49.50
Perf YTD 10.95%
Dividend Est. -
P/FCF -
EPS past 5Y 5.58%
ROI -15.27%
52W High -38.99%
Beta 1.90
Dividend TTM -
Quick Ratio 5.69
Sales past 5Y 43297.50%
Gross Margin 93.75%
52W Low 44.91%
ATR (14) 1.92
Dividend Ex-Date Feb 04, 2014
Current Ratio 5.69
EPS Y/Y TTM 58.80%
Oper. Margin -52.25%
RSI (14) 63.61
Volatility 7.53% 7.75%
Employees 436
Debt/Eq 0.20
Sales Y/Y TTM 328.73%
Profit Margin -41.07%
Recom 1.89
Target Price 49.20
Option/Short Yes / Yes
LT Debt/Eq 0.19
EPS Q/Q 3.53%
Payout -
Rel Volume 2.27
Prev Close 27.51
Sales Surprise -1.70%
EPS Surprise 1.12%
Sales Q/Q -17.01%
Earnings Nov 05 BMO
Avg Volume 1.01M
Price 30.20
SMA20 14.95%
SMA50 21.21%
SMA200 14.17%
Trades
Volume 2,296,558
Change 9.76%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-06-24 Upgrade
Leerink Partners
Market Perform → Outperform
$27 → $39
Oct-16-24 Initiated
Scotiabank
Sector Outperform
Jul-23-24 Initiated
H.C. Wainwright
Buy
$80
Jan-29-24 Upgrade
JP Morgan
Neutral → Overweight
$38 → $40
Dec-15-23 Downgrade
BofA Securities
Buy → Neutral
$35
Dec-08-23 Downgrade
Jefferies
Buy → Hold
$75 → $30
Oct-20-23 Downgrade
Leerink Partners
Outperform → Market Perform
$75 → $20
Oct-20-23 Downgrade
Cantor Fitzgerald
Overweight → Neutral
Mar-21-23 Initiated
Bernstein
Mkt Perform
$37
Feb-01-23 Initiated
Cantor Fitzgerald
Overweight
$62
Dec-20-22 Upgrade
BMO Capital Markets
Market Perform → Outperform
$61 → $66
Dec-13-22 Initiated
Citigroup
Buy
$62
Jun-17-22 Initiated
BMO Capital Markets
Market Perform
$41
Apr-28-22 Initiated
Credit Suisse
Neutral
$62
Jan-05-22 Initiated
Guggenheim
Buy
$130
Oct-19-21 Initiated
SVB Leerink
Outperform
$117
Sep-24-21 Resumed
Stifel
Buy
$85 → $120
Sep-10-21 Initiated
BofA Securities
Buy
$150
May-11-21 Initiated
Redburn
Buy
May-04-21 Initiated
RBC Capital Mkts
Sector Perform
$85
Show Previous Ratings
Dec-09-24 11:10AM
07:15AM
Dec-08-24 01:45PM
Dec-07-24 11:30AM
Dec-06-24 07:00AM
11:30AM
Loading…
Dec-05-24 11:30AM
Dec-04-24 07:00AM
Nov-12-24 04:01PM
Nov-07-24 06:26AM
Nov-06-24 02:12AM
01:40AM
(Thomson Reuters StreetEvents)
Nov-05-24 03:37PM
09:00AM
07:40AM
06:30AM
04:18AM
Loading…
04:18AM
Oct-31-24 03:50AM
Oct-29-24 06:30AM
Oct-23-24 08:47AM
Oct-17-24 03:05PM
Sep-05-24 11:31AM
Aug-14-24 10:27AM
Aug-09-24 10:19AM
Aug-07-24 10:50AM
Aug-06-24 01:54PM
07:45AM
06:30AM
Jul-26-24 07:43AM
Jul-24-24 06:28PM
(Investor's Business Daily)
+7.92%
08:53AM
08:23AM
Loading…
08:23AM
Jul-22-24 04:45PM
Jul-17-24 07:45AM
Jul-16-24 10:12AM
Jul-15-24 06:30AM
Jul-11-24 12:56PM
Jul-09-24 12:00PM
07:00AM
06:25AM
Jul-04-24 02:13PM
Jul-03-24 09:12AM
Jun-27-24 10:02PM
10:26AM
Jun-26-24 06:30AM
Jun-14-24 03:00AM
Jun-06-24 11:31AM
May-30-24 06:30AM
May-14-24 04:00PM
May-13-24 02:18PM
May-09-24 06:49AM
May-08-24 10:52AM
06:30AM
May-07-24 09:02PM
01:54PM
10:17AM
06:30AM
May-01-24 10:01AM
Mar-28-24 11:30AM
Mar-26-24 06:30AM
Feb-28-24 06:30AM
Feb-27-24 04:01PM
(Investor's Business Daily) +25.89%
02:57PM
(Investor's Business Daily)
12:33PM
07:11AM
06:30AM
Feb-20-24 10:00AM
Feb-16-24 02:46PM
(Investor's Business Daily)
Feb-10-24 05:09PM
Feb-07-24 07:35AM
Feb-05-24 06:30AM
Jan-29-24 06:21PM
(Motley Fool) +16.47%
-8.66%
Jan-16-24 01:51PM
09:00AM
Jan-11-24 04:38PM
Jan-08-24 06:30AM
05:52AM
Jan-02-24 06:30AM
Dec-27-23 10:30AM
Dec-15-23 10:22AM
Dec-14-23 06:30AM
Dec-08-23 11:30AM
Nov-30-23 09:55AM
Nov-23-23 11:03AM
09:42AM
Nov-20-23 05:43PM
(InvestorPlace) +11.98%
-9.14%
Nov-18-23 07:15AM
06:49AM
Nov-17-23 12:00PM
Nov-14-23 05:50AM
Nov-10-23 09:55AM
Nov-09-23 01:04PM
Nov-08-23 06:30AM
06:30AM
Nov-06-23 08:02AM
(Investor's Business Daily)
Nov-05-23 08:30AM
Nov-01-23 05:40AM
Oct-31-23 07:09PM
04:04PM
(Investor's Business Daily)
10:01AM
10:00AM
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Ciaramella Giuseppe President Nov 06 '24 Sale 26.36 51,110 1,347,050 109,150 Nov 08 04:10 PM Ciaramella Giuseppe President Oct 14 '24 Option Exercise 2.00 41,754 83,594 211,370 Oct 16 04:44 PM Ciaramella Giuseppe President Oct 14 '24 Sale 26.27 51,110 1,342,752 160,260 Oct 16 04:44 PM Giuseppe Ciaramella Officer Oct 14 '24 Proposed Sale 24.65 102,220 2,519,723 Oct 15 11:37 AM Burrell Terry-Ann Officer Oct 07 '24 Proposed Sale 23.00 185,565 4,267,995 Oct 07 05:00 PM Bellon Christine Chief Legal Officer Oct 01 '24 Sale 23.48 385 9,040 104,209 Oct 02 05:52 PM Cavanagh Bethany J SVP, Finance and Treasurer Oct 01 '24 Sale 23.48 289 6,785 44,931 Oct 02 05:51 PM Evans John M. CEO Sep 30 '24 Sale 24.60 60,000 1,476,024 938,659 Oct 02 05:49 PM JOHN M EVANS Officer Sep 30 '24 Proposed Sale 24.60 60,000 1,476,024 Sep 30 04:51 PM Simon Amy Chief Medical Officer Jul 02 '24 Sale 22.95 748 17,167 68,805 Jul 03 04:05 PM Simon Amy Chief Medical Officer Jul 01 '24 Sale 23.76 502 11,928 69,553 Jul 03 04:05 PM Evans John M. CEO Jun 27 '24 Sale 24.50 60,000 1,470,156 998,343 Jun 28 04:15 PM Simon Amy Chief Medical Officer Apr 02 '24 Sale 30.54 16,530 504,851 70,060 Apr 03 07:43 PM Simon Amy Chief Medical Officer Apr 01 '24 Sale 32.13 7,157 229,954 86,590 Apr 03 07:43 PM Bellon Christine Chief Legal Officer Apr 01 '24 Sale 32.12 3,401 109,240 104,594 Apr 03 07:40 PM Burrell Terry-Ann Chief Financial Officer Apr 01 '24 Sale 32.12 5,446 174,926 70,137 Apr 03 07:39 PM Evans John M. CEO Apr 01 '24 Sale 32.13 18,102 581,617 1,058,343 Apr 03 07:36 PM Ciaramella Giuseppe President Apr 01 '24 Sale 32.12 4,534 145,632 169,616 Apr 03 07:33 PM Evans John M. CEO Mar 28 '24 Sale 33.86 60,000 2,031,402 998,262 Apr 01 04:10 PM FMR LLC See Remark 1 Feb 14 '24 Sale 30.55 900,000 27,496,912 1,235,511 Feb 15 02:34 PM FMR LLC See Remark 1 Feb 13 '24 Sale 30.76 1,565 48,139 2,771,913 Feb 15 02:34 PM Evans John M. CEO Jan 31 '24 Sale 25.33 60,000 1,519,800 1,058,262 Feb 02 04:05 PM Bellon Christine Chief Legal Officer Jan 03 '24 Sale 26.42 1,907 50,383 80,495 Jan 05 04:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite